US Patent 9289476 Tolerogenic synthetic nanocarriers for allergy therapy
Patent 9289476 was granted and assigned to SELECTA BIOSCIENCES INC on March, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+235 characters)
Article
Patent abstract
Disclosed are synthetic nanocarrier compositions, and related methods, comprising immunosuppressants and MHC Class II-restricted epitopes of an allergen that provide tolerogenic immune responses specific to the allergen.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Christopher Fraser0
Roberto A. Maldonado0
Takashi Kei Kishimoto0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09289476 Tolerogenic synthetic nanocarriers for allergy therapy US Patent 9289476 Tolerogenic synthetic nanocarriers for allergy therapy
Infobox
Patent Number
092894760
Patent Number
92894760
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
092894760
Date of Patent
March 22, 2016
0Patent Application Number
134579770
Date Filed
April 27, 2012
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09289476 Tolerogenic synthetic nanocarriers for allergy therapy
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09289476
Date of patent
March 22, 2016
Patent application number
13457977
Date Filed
April 27, 2012
Patent primary examiner
Find more entities like US Patent 9289476 Tolerogenic synthetic nanocarriers for allergy therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
